Voldman, J., Gray, M.L. & Schmidt, M.A. Microfabrication in biology and medicine. Annu. Rev. Biomed. Eng. 1, 401–425 (1999).
Khetani, S.R. & Bhatia, S.N. Engineering tissues for in vitro applications. Curr. Opin. Biotechnol. 17, 524–531 (2006).
Kaplowitz, N. Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 4, 489–499 (2005).
Viravaidya, K. & Shuler, M.L. Incorporation of 3T3–L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies. Biotechnol. Prog. 20, 590–597 (2004).
Chen, C.S., Mrksich, M., Huang, S., Whitesides, G.M. & Ingber, D.E. Geometric control of cell life and death. Science 276, 1425–1428 (1997).
Bhatia, S.N., Balis, U.J., Yarmush, M.L. & Toner, M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J. 13, 1883–1900 (1999).
Pritchard, J.F. et al. Making better drugs: Decision gates in non-clinical drug development. Nat. Rev. Drug Discov. 2, 542–553 (2003).
Gebhardt, R. et al. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab. Rev. 35, 145–213 (2003).
Guillouzo, A. Liver cell models in in vitro toxicology. Environ. Health Perspect. 106 Suppl 2, 511–532 (1998).
LeCluyse, E.L. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur. J. Pharm. Sci. 13, 343–368 (2001).
Sivaraman, A. et al. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 6, 569–591 (2005).
Hewitt, N.J. et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab. Rev. 39, 159–234 (2007).
Donato, M.T., Jimenez, N., Castell, J.V. & Gomez-Lechon, M.J. Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab. Dispos. 32, 699–706 (2004).
Wilkening, S., Stahl, F. & Bader, A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab. Dispos. 31, 1035–1042 (2003).
Whitesides, G.M., Ostuni, E., Takayama, S., Jiang, X. & Ingber, D.E. Soft lithography in biology and biochemistry. Annu. Rev. Biomed. Eng. 3, 335–373 (2001).
Khetani, S.R., Szulgit, G., Del Rio, J.A., Barlow, C. & Bhatia, S.N. Exploring interactions between rat hepatocytes and nonparenchymal cells using gene expression profiling. Hepatology 40, 545–554 (2004).
Madan, A. et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab. Dispos. 31, 421–431 (2003).
Waring, J.F. et al. Isolated human hepatocytes in culture display markedly different gene expression patterns depending on attachment status. Toxicol. In Vitro 17, 693–701 (2003).
Richert, L. et al. Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating. Drug Metab. Dispos. 34, 870–879 (2006).
Rodriguez-Antona, C., Donato, M.T., Pareja, E., Gomez-Lechon, M.J. & Castell, J.V. Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch. Biochem. Biophys. 393, 308–315 (2001).
Isley, W.L. Hepatotoxicity of thiazolidinediones. Expert Opin. Drug Saf. 2, 581–586 (2003).
Kamali, F. The effect of probenecid on paracetamol metabolism and pharmacokinetics. Eur. J. Clin. Pharmacol. 45, 551–553 (1993).
Pirotte, J.H. Apparent potentiation of hepatotoxicity from small doses of acetaminophen by phenobarbital. Ann. Intern. Med. 101, 403 (1984).
Corlu, A. et al. The coculture: a system for studying the regulation of liver differentiation/proliferation activity and its control. Cell Biol. Toxicol. 13, 235–242 (1997).
Eschbach, E. et al. Microstructured scaffolds for liver tissue cultures of high cell density: morphological and biochemical characterization of tissue aggregates. J. Cell. Biochem. 95, 243–255 (2005).
Allen, J.W., Hassanein, T. & Bhatia, S.N. Advances in bioartificial liver devices. Hepatology 34, 447–455 (2001).
Naughton, B.A., Sibanda, B., Weintraub, J.P., San Roman, J. & Kamali, V. A stereotypic, transplantable liver tissue-culture system. Appl. Biochem. Biotechnol. 54, 65–91 (1995).
Kaihara, S. et al. Survival and function of rat hepatocytes cocultured with nonparenchymal cells or sinusoidal endothelial cells on biodegradable polymers under flow conditions. J. Pediatr. Surg. 35, 1287–1290 (2000).
Kane, B.J., Zinner, M.J., Yarmush, M.L. & Toner, M. Liver-specific functional studies in a microfluidic array of primary Mammalian hepatocytes. Anal. Chem. 78, 4291–4298 (2006).
Zeilinger, K. et al. Three-dimensional co-culture of primary human liver cells in bioreactors for in vitro drug studies: effects of the initial cell quality on the long-term maintenance of hepatocyte-specific functions. Altern. Lab. Anim. 30, 525–538 (2002).